1. Home
  2. PARK vs ONCY Comparison

PARK vs ONCY Comparison

Compare PARK & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park Dental Partners Inc.

PARK

Park Dental Partners Inc.

HOLD

Current Price

$18.50

Market Cap

94.5M

Sector

Health Care

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.79

Market Cap

107.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PARK
ONCY
Founded
1972
1998
Country
United States
Canada
Employees
1212
N/A
Industry
Misc Health and Biotechnology Services
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.5M
107.3M
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
PARK
ONCY
Price
$18.50
$0.79
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.33
AVG Volume (30 Days)
22.5K
1.5M
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.06
N/A
Revenue Next Year
$6.17
$2,505.00
P/E Ratio
$6.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.29
$0.77
52 Week High
$22.68
$1.51

Technical Indicators

Market Signals
Indicator
PARK
ONCY
Relative Strength Index (RSI) 46.65 39.59
Support Level $18.81 N/A
Resistance Level $21.06 $1.06
Average True Range (ATR) 1.29 0.07
MACD -0.15 -0.01
Stochastic Oscillator 17.29 4.27

Price Performance

Historical Comparison
PARK
ONCY

About PARK Park Dental Partners Inc.

Park Dental Partners Inc is a dental resource organization (DRO) operating through its subsidiary. It Provides comprehensive business support services including clinical team members, administrative personnel, facilities and equipment to its affiliated general and multi-specialty dental practices throughout Minnesota and Wisconsin. Its network of affiliated dental practices provides both general and specialty dental services, including oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics, under long-term agreements with initial terms of 30-years, with automatic 5-year renewals.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: